1,866
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital

, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , & show all
Pages 705-713 | Received 23 Mar 2020, Accepted 28 Jun 2020, Published online: 05 Aug 2020

References

  • WHO. Pertussis. [accessed 2019 July 25]. https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/pertussis/en/.
  • ECDC. Pertussis. http://ecdc.europa.ue/sites/portal/files/documents/AER_for_2017-pertussis.pdf
  • Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367(11):1012‐1019. doi:10.1056/NEJMoa1200850.
  • Vittucci AC, Spuri Vennarucci V, Grandin A, Russo C, Lancella L, Tozzi AE, Bartuli A, Villani A. Pertussis in infants: an underestimated disease. BMC Infect Dis. 2016 Aug 15;16(1):414. doi:10.1186/s12879-016-1710-0.
  • Saadatian-Elahi M, Plotkin S, Mills KHG, Halperin SA, McIntyre PB, Picot V, Louis J, Johnson DR. Pertussis: biology, epidemiology and prevention. Vaccine. 2016;34(48):5819‐5826. doi:10.1016/j.vaccine.2016.10.029.
  • Signorelli C, Odone A, Cella P, Iannazzo S, D’Ancona F, Guerra R. Infant immunization coverage in Italy (2000-2016). Ann Ist Super Sanità. 2017;53(3):231–37. doi:10.4415/ANN_17_03_09.
  • Bozzola E, Spina G, Russo R, Bozzola M, Corsello G, Villani A. A Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society. Ital J Pediatr. 2018 Jun 14;44(1):67. doi:10.1186/s13052-018-0504-y.
  • Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, Tan T, Knuf M, Rodrigo C, Weil Olivier C, et al. World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Vaccine Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EVASG). Pertussis Prevention: reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines. Front Immunol. 2019 Jul 3;10:1344.
  • WHO. 2018. Official country reported coverage estimates time series. Immunization, vaccines and biologicals. Data, statistics and graphics. http://www.who.int/immunization/monitoring_surveillance/data/en/.
  • Epicentro. 2018. Le vaccinazioni in Italia. www.epicentro.iss.it/vaccini/dati_Ita
  • http://: www.gazzettaufficale.it/eli/id/2017/06/07/17G00095/sg
  • Preston A. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development. Hum Vaccin Immunother. 2016 May 3;12(5):1274–76. doi:10.1080/21645515.2015.1137402.
  • Di Mattia G, Nicolai A, Frassanito A, Petrarca L, Nenna R, Midulla F. Pertussis: new preventive strategies for an old disease. Paediatr Respir Rev. 2019 Feb;29:68–73. doi:10.1016/j.prrv.2018.03.011.
  • Cherry JD, Tan T, Wirsing von Konig C-H, Forsyth KD, Thisyakorn U, Greenberg D, Johnson D, Marchant C, Plotkin S. Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, February 2011. Clin Infect Dis. 2012;54(12):1756–64. doi:10.1093/cid/cis302.
  • Van den Brink G, Wishaupt JO, Douma JC, Hartwig NG, Versteegh FG. Bordetella pertussis: an underreported pathogen in pediatric respiratory infections, a prospective cohort study. BMC Infect Dis. 2014 Sep 30;14(1):526. doi:10.1186/1471-2334-14-526.
  • Ferronato AE, Leite D, Vieira SE. The role of respiratory virus infection in suspected pertussis: A prospective study. J Microbiol Immunol Infect. 2019 Jul 23. [Epub ahead of print]. doi:10.1016/j.jmii.2019.06.009.
  • Stefanelli P, Buttinelli G, Vacca P, Tozzi AE, Midulla F, Carsetti R, Fedele G, Villani A, Concato C. Severe pertussis infection in infants less than 6 months of age: clinical manifestations and molecular characterization. Hum Vaccines Immunotherapeutics. 2017;13(5):1073–77. doi:10.1080/21645515.2016.1276139.
  • Nuolivirta K, Koponen P, He Q, Halkosalo A, Korppi M, Vesikari T, Helminen M. Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis. Pediatr Infect Dis J. 2010;29:1013–15.
  • Frassanito A, Nenna R, Nicolai A, Pierangeli A, Tozzi AE, Stefanelli P, Carsetti R, Concato C, Schiavoni I, Midulla F, et al. Infants hospitalized for Bordetella pertussis infection commonly have respiratory viral coinfections. BMC Infectious Diseases. 2017;17(1):492. doi:10.1186/s12879-017-2567-6.
  • Hochwald O, Bamberger E, Srugo I. The return of pertussis: who is responsible? What can be done? Isr Med Assoc J. 2006;8:301–07.
  • Gregory DS. Pertussis: a disease affecting all ages. Am Fam Physician. 2006;74:420–26.
  • Crespo I, Broner S, Soldevila N, Martínez A, Godoy P, Sala-Farré M-R, Company M, Rius C, Domínguez A, Group of Catalonia TPW, et al. Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010. Hum Vaccin Immunother. 2015;11(1):231–35. doi:10.4161/hv.36156.
  • European Centre for Disease Prevention and Control. Pertussis. Annual epidemiological report 2016. Stockholm (Sweden): ECDC; 2019. p. 1–2.
  • Tan T, Dalby T, Forsyth K, Halperin SA, Heininger U, Hozbor D, Plotkin S, Ulloa-Gutierrez R, Wirsing von König CH. Pertussis across the globe: recent epidemiologic trends from 2000 to 2013. Pediatr Infect Dis J 2015;34(9):222–32. doi:10.1097/INF.0000000000000795.
  • World Health Organization (WHO). Global and regional immunization Profile: European region.www.who.int/immunization/monitoring_surveillance/data/EUR/en/
  • Fiasca F, Gabutti G. Trends in hospital admissions for pertussis infection: a nationwide retrospective observational study in Italy, 2002–2016. Int J Environ Res Public Health. 2019 Nov 15;16(22):4531. doi:10.3390/ijerph16224531.
  • Gonfiantini MV, Carloni E, Gesualdo F, Pandolfi E, Agricola E, Rizzuto E, Iannazzo S, Ciofi Degli Atti ML, Villani A, Tozzi AE, et al. Epidemiology of pertussis in Italy: disease trends over the last century. Euro Surveill. 2014;19(40):20921. doi:10.2807/1560-7917.ES2014.19.40.20921.
  • Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics. 1997 Dec;100(6):E10. doi:10.1542/peds.100.6.e10.
  • Hodge G, Hodge S, MARKUS C, LAWRENCE A, HAN P. A marked decrease in L-selectin expression by leucocytes in infants with Bordetella pertussis infection: leucocytosis explained? Respirology. 2003 Jun;8(2):157–62. doi:10.1046/j.1440-1843.2003.00459.x.
  • Murray EL, Nieves D, Bradley JS, Gargas J, Mason WH, Lehman D, Harriman K, Cherry JD. Characteristics of Severe Bordetella pertussis Infection Among Infants ≤90 Days of Age Admitted to Pediatric Intensive Care Units - Southern California, September 2009-June 2011. J Pediatric Infect Dis Soc. 2013 Mar;2(1):1–6. doi:10.1093/jpids/pis105.
  • Cherry JD. The prevention of severe pertussis and pertussis death in young infants. Expert Review of Vaccines. 2019;18(3):205–08. doi:10.1080/14760584.2019.1581065.
  • Paddock CD, Sanden GN, Cherry J, Gal A, Langston C, Tatti K, Wu K-H, Goldsmith C, Greer P, Montague J, et al. Pathology and pathogenesis of fatal bordetella pertussis infection in infants. Clin Infect Dis. 2008 Aug 1;47(3):328–38. doi:10.1086/589753.
  • Dierig A, Beckmann C, Heininger U. Antibiotic treatment of pertussis: are 7 days really sufficient? Pediatr Infect Dis J. 2015;34(4):444–45. doi:10.1097/INF.0000000000000567.
  • Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev. 2007;(3):CD004404..
  • Prevention. Pertussis: treatment. Atlanta (GA): CDC; 2013. http://www.cdc.gov/pertussis/clinical/treatment.html.
  • Tiwari T, Murphy TV, Moran J, National Immunization Program CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC guidelines. MMWR Recomm Rep. 2005;54(RR-14):1–16.
  • Lozada LE, Royall MJ, Nylund CM, Eberly MD. Development of pyloric stenosis after a 4-day course of oral erythromycin. Pediatr Emerg Care. 2013;29(4):498–99. doi:10.1097/PEC.0b013e31828a3663.
  • Honein MA, Paulozzi LJ, Himelright IM, Lee B, Cragan JD, Patterson L, Correa A, Hall S, Erickson JD. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet. 1999;354(9196):2101–05. doi:10.1016/S0140-6736(99)10073-4.
  • Lebel MH, Mehra S. Efficacy and safety of clarithromycin versus erythromycin B for the treatment of pertussis: a prospective, randomized, single blind trial. Pediatr Infect Dis J. 2001;20:1149–54. doi:10.1097/00006454-200112000-00011.
  • Cherry JD, Wendorf K, Bregman B, Lehman D, Nieves D, Bradley JS, Mason WH, Sande-Lopez L, Lopez M, Federman M, et al. An observational study of severe pertussis in 100 infants ≤120 days of age. Pediatr Infect Dis J. 2018;37(3):202–05. doi:10.1097/INF.0000000000001710.
  • WHO Publication. Pertussis vaccines: WHO position paper-recommendations. Vaccine. 2011;29:23556.
  • Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child. 2013;98(7):552–55. doi:10.1136/archdischild-2012-302968.
  • Dennehy PH, Cortese MM, B??gu?? RE, Jaeger JL, Roberts NE, Zhang R, Rhodes P, Gentsch J, Ward R, Bernstein DI, et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr Infect Dis J. 2006;25(12):1123–31. doi:10.1097/01.inf.0000243777.01375.5b.
  • Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol. 2012;207(suppl3):S3–S8. doi:10.1016/j.ajog.2012.06.068.
  • Kroger AT, Duchin J, Vazquez M. Special situations. general best practice guidelines for immunization: best practices guidance of the Advisory Committee on Immunization Practices (ACIP). [accessed 2019 Jan 10]. www.cdc.gov/vaccines/hcp/acip-recs/general-recs/special-situations.html.
  • Carbone T, McEntire B, Kissin D, Kelly D, Steinschneider A, Violaris K, Karamchandani N. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study. Pediatrics. 2008;121(5):e1085–e1090. doi:10.1542/peds.2007-2059.
  • Bonhoeffer J, Siegrist C-A, Heath PT. Immunisation of premature infants. Arch Dis Child. 2006;91(11):929–35. doi:10.1136/adc.2005.086306.
  • Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J. 2009;28(3):194–98. doi:10.1097/INF.0b013e31818c9032.
  • Gabutti G, Azzari C, Bonanni P, Prato R, Tozzi AE, Zanetti A, Zuccotti G. Pertussis. Hum Vaccin Immunother. 2015;11(1):108–17. doi:10.4161/hv.34364.
  • Swamy GK, Wheeler SM. Neonatal pertussis, cocooning and maternal immunization. Expert Rev Vaccines. 2014;13(9):1107–14. doi:10.1586/14760584.2014.944509.
  • Winter K, Zipprich J, Harriman K. Pertussis in California: A tale of 2 epidemics. Pediatr Infect Dis J. 2018 Apr;37(4):324–28. doi:10.1097/INF.0000000000001761.
  • Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Fry NK, Ramsay M. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis. 2015;60(3):333–37. doi:10.1093/cid/ciu821.
  • Cherry JD. Editorial commentary: tetanus-diphtheria-pertussis immunization in pregnant women and the prevention of pertussis in young infants. Clin Infect Dis. 2015;60(3):338–40. doi:10.1093/cid/ciu823.
  • Amirthalingam G, Campbell H, Ribeiro S, Fry NK, Ramsay M, Miller E, Andrews N. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Dis. 2016 Dec 1;63(suppl 4):S236–S243. doi:10.1093/cid/ciw559.
  • CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months. Advisory Committee on Immunization Practices (ACIP), 2011. MMWR. 2011;60:1426.
  • CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women – advisory Committee on Immunization Practices (ACIP), 2013. MMWR. 2012;62:131–35.
  • Vizzotti C, Neyro S, Katz N, Juárez MV, Perez Carrega ME, Aquino A, Kaski Fullone F. Maternal immunization in Argentina: a storyline from the prospective of a middle income country. Vaccine. 2015;33(47):6413–19. doi:10.1016/j.vaccine.2015.07.109.
  • Maertens K, Caboré RN, Huygen K, Hens N, Van Damme P, Leuridan E. Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study. Vaccine. 2016;34(1):142–50. doi:10.1016/j.vaccine.2015.10.100.
  • Immunize Australia Program. 2015. Pregnant women. www1.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi3903c.htm.
  • Agricola E, Gesualdo F, Alimenti L, Pandolfi E, Carloni E, D’Ambrosio A, Russo L, Campagna I, Ferretti B, Tozzi AE, et al. Knowledge attitude and practice toward pertussis vaccination during pregnancy among pregnant and postpartum Italian women. Hum Vaccin Immunother. 2016 Aug 2;12(8):1982–88. doi:10.1080/21645515.2016.1188242.
  • D’Alessandro A, Napolitano F, D’Ambrosio A, Angelillo IF. Vaccination knowledge and acceptability among pregnant women in Italy. Hum Vaccin Immunother. 2018 Jul 3;14(7):1573–79. doi:10.1080/21645515.2018.1483809.
  • Atkins KE, Fitzpatrick MC, Galvani AP, Townsend JP. Cost-effectiveness of pertussis vaccination during pregnancy in the United States. Am J Epidemiol. 2016;183(12):1159–70. doi:10.1093/aje/kwv347.
  • Poirrier JE, Mungall B, Lee IH, Terlinden A, Curran D. Cost-effectiveness of maternal immunisation for pertussis in New Zealand. Value Health. 2014;17(7):A806. doi:10.1016/j.jval.2014.08.520.
  • World Health Organization. Summary of the Pertussis vaccines: WHO position paper-September 2015. www.who.int/immunization/documents/pertussis_pp_2015_summary.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.